<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">26008213</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-1041</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>71</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2015</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of clinical pharmacology</Title>
                <ISOAbbreviation>Eur. J. Clin. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A review on colistin nephrotoxicity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>801-10</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00228-015-1865-4</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Colistin is an antibiotic that was introduced many years ago and was withdrawn because of its nephrotoxicity. Nowadays, reemergence of this antibiotic for multi-drug resistant Gram-negative infections, and a new high dosing regimen recommendation increases concern about its nephrotoxicity. This review attempts to give a view on colistin nephrotoxicity, its prevalence especially in high doses, the mechanism of injury, risk factors, and prevention of this kidney injury.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">The data collection was done in PubMed, Scopus and Cochrane databases. The keywords for search terms were &quot;colistin&quot;, &quot;nephrotoxicity&quot;, &quot;toxicity&quot;, &quot;renal failure&quot;, &quot;high dose&quot;, and &quot;risk factor&quot;. Randomized clinical trials and prospective or retrospective observational animal and human studies were included. In all, 60 articles have been reviewed.</AbstractText>
                <AbstractText Label="RESULT AND CONCLUSION" NlmCategory="CONCLUSIONS">Colistin is a nephrotoxic antibiotic; a worldwide increase in nosocomial infections has led to an increase in its usage. Nephrotoxicity is the concerning adverse effect of this drug. The mechanism of nephrotoxicity is via an increase in tubular epithelial cell membrane permeability, which results in cation, anion and water influx leading to cell swelling and cell lysis. There are also some oxidative and inflammatory pathways that seem to be involved in colistin nephrotoxicity. Risk factors of colistin nephrotoxicity can be categorized as dose and duration of colistin therapy, co-administration of other nephrotoxic drugs, and patient-related factors such as age, sex, hypoalbuminemia, hyperbilirubinemia, underlying disease and severity of patient illness.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ordooei Javan</LastName>
                    <ForeName>Atefeh</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Niyayesh Cross Road, Valiasr Street, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shokouhi</LastName>
                    <ForeName>Shervin</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sahraei</LastName>
                    <ForeName>Zahra</ForeName>
                    <Initials>Z</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2015</Year>
                <Month>05</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Eur J Clin Pharmacol</MedlineTA>
            <NlmUniqueID>1256165</NlmUniqueID>
            <ISSNLinking>0031-6970</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>Z67X93HJG1</RegistryNumber>
                <NameOfSubstance UI="D003091">Colistin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003091" MajorTopicYN="N">Colistin</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D054796" MajorTopicYN="N">Drug Dosage Calculations</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>02</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2015</Year>
                <Month>05</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2015</Year>
                <Month>5</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2015</Year>
                <Month>5</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>3</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">26008213</ArticleId>
            <ArticleId IdType="doi">10.1007/s00228-015-1865-4</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Antimicrob Chemother. 2012 Feb;67(2):452-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22127588</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 Dec 1;37(11):e154-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14614688</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2010 Dec;138(6):1333-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20558557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2010 Oct;54(10):4503-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20660694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Purif. 2009;28(3):165-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19590184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2009 Aug;53(8):3430-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19433570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacotherapy. 2011 Dec;31(12):1257-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22122186</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2010 Mar;35(3):297-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20045293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21555763</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>S Afr Med J. 2014 Mar;104(3):183-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24897820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Purif. 2014;37(4):291-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25096804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephron Clin Pract. 2011;117(3):c284-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20847571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Crit Care. 2004 Dec;10 (6):476-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15616389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect Chemother. 2012 Dec;18(6):872-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22644081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2010 May;65(5):1019-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20299494</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2009 Nov;34(5):434-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19726164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2003 Oct;7(5):R78-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12974973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Ann Dist Columbia. 1963 Oct;32:408-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14049612</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2011 Feb;62(2):187-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21129401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intensive Care. 2011 Aug 02;1(1):30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21906382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Jun;54(12):1727-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22423122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2010 May;35(5):473-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20089383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Sci. 2014 Feb;137(2):278-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24189134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2013 Aug 14;17(4):R174</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23945197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2006 Oct;28(4):366-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16971093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Mar 1;54(5):670-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22322268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S89-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16894521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Jun;54(12):1720-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22423120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2014 Apr;43(4):349-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24439066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2010 Dec 1;51(11):1238-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20973727</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ren Fail. 2013 Sep;35(8):1130-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23879363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2006 Sep;6(9):589-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16931410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2013 Aug 19;13:380</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23957376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2005 Jan;25(1):11-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15620821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Toxicol Pharmacol. 2014 May;37(3):960-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24709323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2003 May 1;36(9):1111-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12715304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Assoc Med Bras (1992). 2009 Nov-Dec;55(6):752-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20191233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Nephrol. 2013 Dec;80(6):405-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24120670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intensive Care. 2011 May 25;1(1):14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21906345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2013 Aug;57(8):3463-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23629704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2011 Jan;37(1):141-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20845026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2005 May 1;40(9):1333-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15825037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intern Med. 2011;50(9):1009-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21532223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacotherapy. 2010 Dec;30(12):1279-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21114395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2008 Mar;56(3):185-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18280570</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2013 Aug;42(2):178-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23769664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Antimicrob Agents. 2005 Dec;26(6):504-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16280245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2007 Dec;60(6):1206-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17878146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2008 Jun;56(6):432-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18501431</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2006 Feb;10(1):R27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16507149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2011 Sep;55(9):4044-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21709095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2006 Jun;50(6):1953-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16723551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Nov;53(9):879-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21900484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2009 Jun 15;48(12):1724-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19438394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Infect Dis. 2009 Dec;22(6):535-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19797945</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>